Intelligence Β· Clinical Pipeline
R&D Pipeline Programs
ClinicalTrials.gov programs linked to pharma sponsors β phase, modality, and trial IDs for BD and competitive intelligence.
- Programs indexed
- 20,548
- Companies
- 1,769
- Drugs tracked
- 4,797
Quick answer
NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text β searchable for business development and competitive intelligence.
-
Ursodeoxycholic acid combined with total glucosides of paeony
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Hepatitis
1 trial -
Use of an Implantable Loop Recorder
Rhythm Pharmaceuticals Netherlands B.V.
Syncope
1 trial -
VAB-7
The First People's Hospital of Lianyungang
Helicobacter Pylori
1 trial -
VENDY
Summit Therapeutics
Harm Reduction
1 trial -
VYEPTI 100 mg concentrate for solution for infusion
H. Lundbeck A/S
Chronic Migrane, Migrane, Medication Overuse Headache
1 trial -
Vabysmo 120 mg/mL solution for injection
Hoffmann-La Roche
Neovascular Age-Related Macular Degeneration
1 trial -
Vabysmo 120 mg/mL solution for injection in pre-filled syringe
The George Institute
SUBRETINAL HYPERREFLECTIVE MATERIAL
1 trial -
Vaccination to prevent hepatitis B virus infection
BRIGHT MINDS BIOSCIENCES INC.
Hepatitis B
1 trial -
Vancomycin
United Therapeutics Europe Ltd
Open Fracture
1 trial -
Vancomycin
The First People's Hospital of Lianyungang
Blood Stream Infections
1 trial -
Vaxigrip Tetra, suspensie voor injectie in een voorgevulde spuit Quadrivalent griepvaccin (gesplitst virion, geΓ―nactiveerd), Fluenz Tetra nasal spray suspension Influenza vaccine (live attenuated, nasal)
Disc Medicine
healthy individuals
1 trial -
Velaglucerase Alfa
Takeda
Gaucher Disease
4 trials -
Vemlidy
Hospital Authority, Hong Kong
Chronic Hepatitis b
1 trial -
Vemurafenib
Hoffmann-La Roche
Neoplasms
1 trial -
Video directly observed therapy with contingency management
BRIGHT MINDS BIOSCIENCES INC.
HIV Infections
1 trial -
Vifor
The First People's Hospital of Lianyungang
Malnutrition
1 trial -
Voltaren SPORT, 11,6 mg/g, ΕΌel, Voltaren MAX, 23,2 mg/g, ΕΌel
HALEON AUSTRALIA PTY LTD
Mild/non-serious osteoarthritis (OA) of the knee.
1 trial -
Vonoprazan
The First People's Hospital of Lianyungang
Ulcers, Gastric
1 trial -
Vonoprazan
The First People's Hospital of Lianyungang
Helicobacter Pylori Infection
2 trials -
Vonoprazan and Amoxicillin for the first 7 days
The First People's Hospital of Lianyungang
Helicobacter Pylori Infection
1 trial -
Vortioxetine
Takeda
Healthy Volunteers
1 trial -
Vyndaqel 61 mg soft capsules
Monte Rosa Therapeutics
Transthyretin cardiac amyloidosis
1 trial -
Vyvgart 20 mg/mL concentrate for solution for infusion
The George Institute
Patients affected by generalized myasthenia gravis
1 trial -
Wangbi granules
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Rheumatoid Arthritis
1 trial
Frequently asked questions
What is the NovaPharmaNews pipeline directory?
It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1β3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.
Where does pipeline data come from?
Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync β verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.
How do I find pipeline programs by company or phase?
Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.
Data attribution and licensing: Data sources